Table 1.
Cell markers on eMSCs and MenSCs
| Reference cell type/lineage for the different set of markers | Marker | Endometrial mesenchymal stromal cells |
Menstrual blood-derived stromal cells |
||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| eMSC | SUSD2+ eMSCs | CD117 + MenSCs | ERC | MenSCs | MMCs | ||||||||||||||
| Mesenchymal (bm-MSC) | CD29 | + | + | + | + | + | + | + | + | + | + | + | + | ||||||
| CD44 | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | ||||
| CD73 | + | + | + | + | + | + | + | + | + | + | + | + | + | + | |||||
| CD90 | + | + | + | + | + | + | + | + | + | + | + | + | + | ||||||
| CD105 | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | ||||
| STRO1 | – | – | + | – | – | – | |||||||||||||
| CD117 | + | + | – | – | |||||||||||||||
| CD10 | |||||||||||||||||||
| Endothelial | CD31 | – | – | – | – | – | |||||||||||||
| Hematopoietic | CD34 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | ||||
| CD45 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |||||
| HLA-DR | – | – | – | – | – | ||||||||||||||
| Pericyte | CD146 | + | + | + | + | + | + | + | + | + | |||||||||
| CD140b | + | + | + | + | + | ||||||||||||||
| SUSD2 | + | + | |||||||||||||||||
| Pluripotency | OCT4 | + | + | + | + | + | – | ||||||||||||
| NANOG | – | – | – | ||||||||||||||||
| SSEA4 | + | – | + | + | |||||||||||||||
| hTERT | + | ||||||||||||||||||
| Other markers analyzed | Negative expression | CD106- CD184- CD271- CD325- | MHCII - CD38- | CD14- CD38- | CD14 - CD50 - CD133 - HLA-DR - | CD133- CD38- | CD38- CD133- | CD38- | CD14- CD106- CD133- | HLADR- | CD14- CD133- | CD14- CD16- CD19- CD133- | |||||||
| Positive expression | CD166+ | MHCI + CD166 + CD9+ | CD9+ CD59 + CD41a+ | CD13 + CD54 + CD55 + CD59+ HLA-ABC | CD10+ | CD9+ CD10+ | CD166+ | CD10+ | CD13+ | CD10 + CD55 + CD59 + CD166+ | CD13 + CD54 + CD166 + CD59+ HLA-ABC+ | ||||||||
| References | (Schwab and Gargett, 2007) | (Gargett et al., 2009) | (Rajaraman et al., 2013) | (Zlatska et al., 2017) | (Masuda et al., 2012) | (Gurung et al., 2015) | (Patel et al., 2008) | (Meng et al., 2007) (∗) | (Cui et al., 2007) | (Musina et al., 2008) | (Darzi et al., 2012) | (Kazemnejad et al., 2012) | (Li et al., 2013) | (Khanjani et al., 2014) | (Khanmohammadi et al., 2014) | (Lopez-Caraballo et al., 2020) | (Hida et al., 2008) (∗) | (Sugawara et al., 2014) | |
Summary of phenotypic marker expression by endometrial mesenchymal stem cells (eMSCs) or menstrual blood-derived stromal/stem cells (MenSCs) isolated by plastic adherence or by specific marker (SUSD2+ in eMSCs and CD117+ in MenSCs). Different designations of MenSCs are also included according to the publication where they were described (ERC, endometrial regenerative cells; MMCs, menstrual blood-derived mesenchymal cells; eMSCs, endometrial mesenchymal stem/stromal cells) (∗) No flow cytometry histogram or dot plots were shown.